$BIVI
Biovie Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Carson City, NV
BIVI chart
What traders are saying about $BIVI
Latest postsBiovie Inc. news
- Small cap wrap: Montero Mining, Tiziana Life Sciences, BioVie, Ocean Power Technologies...
Proactive financial news ·
- BioVie Inc. (BIVI) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- BioVie identifies two Long COVID patient groups with distinct responses to bezisterim
proactiveinvestors.com ·
- BioVie presents Long COVID biomarker data at NIH workshop
StreetInsider ·
- BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop
Yahoo Finance ·
- BioVie Presents New Biomarker Data from the ADDRESS-LC
GlobeNewswire ·
- Biovie (BIVI) Stock Price, Chart & Analysis
www.debelegger.nl ·
- Fusion Power, Global Capital, Branded Streaming and Neurology Breakthroughs: New to The Street Show #779 Premieres Tonight on Bloomberg Television
Yahoo Finance ·
- Biovie Stock Price Forecast. Should You Buy BIVI?
StockInvest.us ·
- BioVie Closes $4.74 Million Registered Direct Offering
TipRanks ·
- BioVie 3Q 2026: EPS ($0.68) — 10-Q Summary
TradingView ·
- With no revenue expected in the foreseeable future, BioVie (BIVI) posts a wider quarterly loss.
Stock Titan ·
Biovie Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | -$22.1M | -$17.5M | -$32.1M | -$50.3M |
| Diluted EPS | $-3.05 | $-12.12 | $-73.05 | $-15.47 |
| Total assets (year end) | – | $22.5M | $25.7M | $21.5M |
| Cash and equivalents (year end) | – | $20.5M | $24.4M | $20.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-QFORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2026
- 8-KCURRENT REPORT
- DEF 14ADEF 14A
- 8-KCURRENT REPORT
- 10-KFORM 10-K FOR PERIOD ENDED JUNE 30, 2026
- 8-KCURRENT REPORT
- S-1FORM S-1 REGISTRATION STATEMENT
- 10-QFORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
- 10-QFORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QFORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025
About Biovie Inc.
- Ticker
- BIVI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carson City, NV
- Incorporated in
- NV
- Fiscal year end
- June 30
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC.
Frequently asked questions
What exchange is Biovie Inc. listed on?
Biovie Inc. trades on the Nasdaq under the ticker symbol BIVI.
What industry is Biovie Inc. in?
Biovie Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Biovie Inc. headquartered?
Biovie Inc.'s business address on file with the SEC is in Carson City, NV.
When does Biovie Inc.'s fiscal year end?
Biovie Inc.'s fiscal year ends on June 30.